News - ViiV Healthcare

Filter

Current filters:

ViiV Healthcare

Popular Filters

ViiV and Shionogi say dolutegravir meets primary endpoint in HIV

02-04-2012

ViiV Healthcare, the HIV/AIDS joint venture of UK drugs giant GlaxoSmithKline (LSE: GSK) and US behemoth…

Anti-viralsdolutegravirGlaxoSmithKlinePfizerPharmaceuticalResearchShionogiViiV Healthcare

Mylan gets tentative FDA approval for generic Epzicom

23-02-2012

US generics major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Laboratories has received tentative…

Anti-viralsEpzicomGenericsGlaxoSmithKlineMylan LaboratoriesNorth AmericaPfizerRegulationViiV Healthcare

ViiV Healthcare announces 16 new grantees for 2011/2012 to prevent mother-to-child HIV transmission

13-10-2011

ViiV Healthcare, the HIV/AIDS joint venture of UK drugs giant GlaxoSmithKline (LSE: GSK) and US behemoth…

Anti-viralsFinancialGlaxoSmithKlineHealthcarePfizerPharmaceuticalRest of the WorldViiV Healthcare

ViiV Healthcare withdraws applications of once-daily Celsentri/Selzentry

21-09-2011

UK-based ViiV Healthcare, a global specialist HIV company established in November 2009 by UK pharma giant…

Anti-viralsCelsentriEuropeGlaxoSmithKlineNorth AmericaPfizerPharmaceuticalRegulationSelzentryViiV Healthcare

Back to top